Top

Journal of Public Health

Published in:

01-08-2020 | CABG | Original Article

Cost-effectiveness of coronary clinical intervention: a retrospective analysis

Authors: K. R. Pillai, Sunaina G. Fernandes

Published in: Journal of Public Health | Issue 4/2020

Abstract

Aim

The study was to conduct an economic evaluation of two alternative healthcare interventions from the point of view of allocative efficiency in a healthcare setting. We compared cost-effectiveness of coronary artery bypass graft (CABG) in relation to percutaneous transluminal coronary angioplasty (PTCA) conducted on patients with double vessel disease.

Method

The approach of the study was more economics-oriented than of a clinical flavor. It was a retrospective study conducted in a tertiary level private hospital in India. We explored the record of patients who underwent these procedures between 2010 and 2013 to obtain the location of the sample frame. Details of sample subjects were provided to the hospital information system to obtain data pertaining to cost. The outcome of the clinical intervention was calculated using the quality-adjusted life-year (QALY) approach with literature support and physician consultation.

Results

The result of the study indicates that PTCA is clinically better and more cost-effective than CABG. The study would have provided more value to the policy makers had it been conducted prospectively through patient contacts.

Conclusion

Prevelance of a collaborative payer mechanism is advisable to contain the mounting cost of coronary clinical interventions, as long-term effects calls for higher costs.

Available only for authorised users

Ahn JM, Roh JH, Kim YH, Park DW, Yun SC, Lee PH, ..., & Park SW (2015). Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study. J Am Coll Cardiol 65(20): 2198–2206CrossRef

Anderson GF, Chu E (2007) Expanding priorities—confronting chronic disease in countries with low income. N Engl J Med 356(3):209–211CrossRef

Aronson D, Edelman ER (2010) Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord. 11(1):75–86CrossRef

Aziz O, Rao C, Panesar SS, Jones C, Morris S, Darzi A, Athanasiou T (2007) Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 334(7594):617CrossRef

Christopher JL, Murray CJL, Raymond CWH, Louis N, Niels T, Anthony R, Carlene MM L, David BE (2003) Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk, in Edejer TT, Baltuseen R, Adam TR, Acharya A, Evens DB, Murray CLJ (eds) Making Choices in Health: WHO guide to Cost-Effectiveness Analysis. World Health Organization, Geneva, pp 237–276

Danchin N, Urban P (1999) PTCA versus CABG: a different interpretation of results of randomized trials comparing both treatments. Heart 82:413–414CrossRef

Dowdy DW, Steingart KR, Pai M (2011) Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 8(8):e1001074CrossRef

Drummond MF, Sculpher MJ, Torrance GW, O’Brieu BJ, Stoddart GL (2005) Methods for the economic evaluation of healthcare programmes, 3rd edn. Oxford University Press, New York

Edejer TT, Baltuseen R, Adam T, Hutubessy R, Acharya A, Evens DB, Murray CLJ (eds) (2003) Making choices in health: WHO guide to cost-effectiveness analysis. World Health Organization, Geneva

Garber AM (2000) Advances in cost-effectiveness analysis of health intervention. In: Culyer AJ, Newhouse JP (eds) Handbook of health economics, Vol I. Elsevier, Amsterdam, pp 181–224

Hajizadeh M, Connelly LB, Butler JR, Khosravi A (2012) Unmet need and met unneed in health care utilisation in Iran. Int J Soc Econ 39(6):400–422CrossRef

Henderson JW (2012) Health economics & policy, 5th edn. South Western, USA

Hernández RA, Jenkinson D, Vale L, Cuthbertson BH (2014) Economic evaluation of nurse-led intensive care follow-up programmes compared with standard care: the PRaCTICaL trial. Eur J Health Econ 15(3):243–252CrossRef

Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG et al (2011) ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardio 58(24):e123–e210

Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA (2005) Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 331(7530):1431–1437CrossRef

Husereau D, Loder E, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J (2013) Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Eur J Health Econ 14:367–372CrossRef

Karki DB, Neopane A (2003) A review on percutaneous coronary intervention vs. coronary artery bypass graft surgery. Kathmandu University Medical Journal (KUMJ) 1(4):284

Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X (2010) Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 33(8):1872–1894CrossRef

Murray CJ, Evans DB, Acharya A, Baltussen RM (2000) Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 9(3):235–251CrossRef

Murray CJL, Evans DB, Acharya A, Baltussen R (2003) Development of WHO guidelines on generalized cost-effectiveness analysis. In: Edejer TT, Baltuseen R, Adam TR, Acharya A, Evens DB, Murray CLJ (eds) Making choices in health: WHO guide to cost-effectiveness analysis. World Health Organization, Geneva, pp 125–150

O’Reilly J, Lowson K, Green J, Young JB, Forster A (2008) Post-acute care for older people in community hospitals—a cost-effectiveness analysis within a multi-centre randomised controlled trial. Age Ageing 37(5):513–520CrossRef

Palmerini T, Biondi-Zoccai G, Reggiani LB, Sangiorgi D, Alessi L, De Servi S, et al (2012) Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. J Am Coll Cardiol 60(9): 798–805CrossRef

Phillips CJ (2005) Health economics: an introduction for health professionals. Blackwell, MassachusettsCrossRef

Pocock SJ, Gersh BJ (2014) Do current clinical trials meet society’s needs?: a critical review of recent evidence. J Am Coll Cardiol 64(15):1615–1628CrossRef

Seo MK, Baker P, Ngo KNL (2014) Cost-effectiveness analysis of vaccinating children in Malawi with RTS, S vaccines in comparison with long-lasting insecticide-treated nets. Malar J 13(1):66CrossRef

Steenstra IA, Anema JR, van Tulder MW, Bongers PM, de Vet HC, van Mechelen W (2006) Economic evaluation of a multi-stage return to work program for workers on sick-leave due to low back pain. J Occup Rehabil 16:557–578CrossRef

Vijgen SMC, Van Baal PHM, Hoogenveen RT, De Wit GA, Feenstra TL (2007) Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students. Health Educ Res 23(2):310–318CrossRef

Wallerstedt SM, Bladh L, Ramsberg J (2012) A cost-effectiveness analysis of an in-hospital clinical pharmacist service. BMJ 2(1):e000329

WHO (2008) World health report. World Health Organization, Geneva

WHO (2010) Global status report on non-communicable diseases. World Health Organization, Geneva

WHO (2011) Non-communicable diseases country profile. World Health Organization, Geneva

WHO (2012) Guidelines to a cost effective analysis. World Health Organization, Geneva

WHO (2016) Fiscal policies for diet and prevention of noncommunicable diseases; technical meeting report. World Health Organization, Geneva

Wonderling D, Gruen R, Black N (2005) Introduction to health economics. Open University Press, England

Yong YV, Shafie AA (2014) Economic evaluation of enhanced asthma management: a systematic review. Pharm Pract 12(4):493–505

Title: Cost-effectiveness of coronary clinical intervention: a retrospective analysis
Authors: K. R. Pillai
Sunaina G. Fernandes
Publication date: 01-08-2020
Publisher: Springer Berlin Heidelberg
Keywords: CABG
CABG
Published in: Journal of Public Health / Issue 4/2020
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-019-01029-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cost-effectiveness of coronary clinical intervention: a retrospective analysis

Abstract

Aim

Method

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aim

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2020

Vision care in areas of under-developed infrastructure

Results of primary health care intervention for prevention of hospitalizations and mortality due to hypertension in Brazil, 2000–2015

How social business innovates health care: two cases of social value creation leading to high-quality services

Innovative tool for health promotion for at-risk Thai people with hypertension

Sequential screening in the early diagnosis of colorectal cancer in the community

Children’s social communication skills and electronic screen exposure, perinatal, and other risk factors